Literature DB >> 14985073

Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure.

Alexander Bauer1, Amy D McDonald, J Kevin Donahue.   

Abstract

OBJECTIVE: Develop and evaluate a model of persistent atrial fibrillation (AF) and severe congestive heart failure (CHF).
METHODS: A single-chamber atrial pacemaker was implanted in pigs (20-30 kg). Burst atrial pacing at 42 Hz led to development of persistent AF. Immediately and 20 days after activation of the burst pacing protocol, animals underwent echocardiography. Heart rate, rhythm and general condition were monitored on a daily basis. After 20 days of atrial fibrillation, the animals were sacrificed. Conventional histological methods were used to evaluate microscopic structural changes.
RESULTS: In the pig model, persistent atrial fibrillation developed 5 +/- 0.7 days after initiation of the burst protocol. Ventricular response rate was 274 +/- 5 bpm during atrial fibrillation, leading to a tachycardiomyopathy. Heart failure symptoms occurred approximately 15 days after initiation of burst pacing. Increases in QT interval on electrocardiogram, heart weight-to-body weight ratio, and laboratory values suggestive of a hypercatecholaminergic state, as well as liver and kidney dysfunction occurred during the 20-day duration of the study. Microstructural changes consistent with cellular hypertrophy, variable fibrosis, myolysis and apoptosis were found in the atria and ventricles of the study animals.
CONCLUSIONS: The combined entity of atrial fibrillation and severe congestive heart failure leads to multiple organ dysfunction, ultrastructural and microscopic cardiac changes. Cellular hypertrophy, fibrosis and apoptosis are more prominent in this combined entity than previously reported models of lone atrial fibrillation or heart failure. This model can be used for further investigation into the pathophysiology and treatment of atrial fibrillation and advanced heart failure.

Entities:  

Mesh:

Year:  2004        PMID: 14985073     DOI: 10.1016/j.cardiores.2003.12.013

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

1.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 2.  Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.

Authors:  David D McManus; Amir Y Shaikh; Fnu Abhishek; Ramachandran S Vasan
Journal:  Crit Pathw Cardiol       Date:  2011-03

3.  Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

Authors:  Tomonori Igarashi; J Emanuel Finet; Ayano Takeuchi; Yoshihisa Fujino; Maria Strom; Ian D Greener; David S Rosenbaum; J Kevin Donahue
Journal:  Circulation       Date:  2011-12-08       Impact factor: 29.690

4.  Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults.

Authors:  Ayman A Hussein; Traci M Bartz; John S Gottdiener; Nona Sotoodehnia; Susan R Heckbert; Donald Lloyd-Jones; Jorge R Kizer; Robert Christenson; Oussama Wazni; Christopher deFilippi
Journal:  Heart Rhythm       Date:  2015-01-17       Impact factor: 6.343

5.  Myocardial sleeves of pulmonary veins and atrial fibrillation: a postmortem histopathological study of 100 subjects.

Authors:  Ivo Steiner; Petra Hájková; Jirí Kvasnicka; Ivana Kholová
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

6.  Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs.

Authors:  Derek J Dosdall; Ravi Ranjan; Koji Higuchi; Eugene Kholmovski; Nathan Angel; Li Li; Rob Macleod; Layne Norlund; Aaron Olsen; Christopher J Davies; Nassir F Marrouche
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-28       Impact factor: 4.733

Review 7.  Information learned from animal models of atrial fibrillation.

Authors:  J Emanuel Finet; David S Rosenbaum; J Kevin Donahue
Journal:  Cardiol Clin       Date:  2009-02       Impact factor: 2.213

8.  Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation.

Authors:  Zhao Liu; Julie A Hutt; Barur Rajeshkumar; Yoshihiro Azuma; Kailai L Duan; J Kevin Donahue
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-23       Impact factor: 5.209

9.  Anatomical pitfalls during encircling cryoablation of the left atrium for atrial fibrillation therapy in the pig.

Authors:  Douglas L Jones; Gerard M Guiraudon; Allan C Skanes; Colette M Guiraudon
Journal:  J Interv Card Electrophysiol       Date:  2008-03-07       Impact factor: 1.900

Review 10.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.